tiprankstipranks
Trending News
More News >

Chimeric Therapeutics Announces Director’s Interest Change

Story Highlights
Chimeric Therapeutics Announces Director’s Interest Change

Don’t Miss TipRanks’ Half-Year Sale

Chimeric Therapeutics Ltd. ( (AU:CHM) ) has provided an announcement.

Chimeric Therapeutics Ltd. announced a change in the director’s interest notice, specifically regarding Lesley Russell’s disposal of 2,750,000 unlisted options. This change reflects the expiry of unlisted options, leaving the director with 1,739,130 shares and no options, which may impact the company’s governance and stakeholder interests.

More about Chimeric Therapeutics Ltd.

Chimeric Therapeutics Ltd. is a company listed on the Australian Securities Exchange (ASX: CHM), involved in the biotechnology industry, focusing on the development of innovative therapies.

Technical Sentiment Signal: Sell

Current Market Cap: A$8.06M

See more insights into CHM stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1